Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales: the Importance of Heteroresistance for Growth Outcome

Oral fosfomycin for the treatment of chronic bacterial prostatitis

(2019) Ilias Karaiskos et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence of fosfomycin resistance among ESBL-producing Escherichia coli isolates in the community, Switzerland

(2019) Linda Mueller et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

In Vitro Susceptibility of Urinary Isolates of Escherichia coli to First- and Second-Line Empirically Prescribed Oral Antimicrobial Agents: CANWARD Surveillance Study Results for Canadian Outpatients from 2007 to 2016

(2019) James A. Karlowsky et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Trends and prediction of antimicrobial susceptibility in urinary bacteria isolated in European emergency departments: the EuroUTI 2010-2016 Study

(2019) Alice Quaegebeur et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Oral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients – results of a Spanish multicenter cohort

(2019) Francisco López‐Medrano et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants (PROOF)

(2018) E Wenzler et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli

(2018) George G. Zhanel et al.   Canadian Journal of Infectious Diseases & Medical Microbiology

High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers

(2018) R.A. Wijma et al.   CLINICAL MICROBIOLOGY AND INFECTION

Fosfomycin Etest for Enterobacteriaceae: Interobserver and interlaboratory agreement

(2018) S.P. van Mens et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Nitrofurantoin vs Fosfomycin

(2018) Rupak Datta et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women

(2018) Angela Huttner et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†

(2018) Peter M Hawkey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Susceptibility of ESBL Escherichia coli and Klebsiella pneumoniae to fosfomycin in the Netherlands and comparison of several testing methods including Etest, MIC test strip, Vitek2, Phoenix and disc diffusion

(2018) Wouter van den Bijllaardt et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences

(2018) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Fosfomycin-Trometamol for Urinary Tract Infections in Kidney Transplant Recipients

(2018) T. ten Doesschate et al.   TRANSPLANTATION

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)

(2018) Thijs ten Doesschate et al.   BMC INFECTIOUS DISEASES

Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model

(2017) Iain J Abbott et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacodynamics of colistin and fosfomycin: a ‘treasure trove’ combination combats KPC-producing Klebsiella pneumoniae

(2017) Miao Zhao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A fast and sensitive LC–MS/MS method for the quantification of fosfomycin in human urine and plasma using one sample preparation method and HILIC chromatography

(2017) Rixt A. Wijma et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model

(2016) Brian VanScoy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy and Safety of Oral Fosfomycin for Urinary Tract Infections in Hospitalized Patients

(2016) Shauna Jacobson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fosfomycin

(2016) Matthew E. Falagas et al.   CLINICAL MICROBIOLOGY REVIEWS

Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature

(2016) Konstantinos Z. Vardakas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis

(2016) Justin T. Seroy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fosfomycin: Resurgence of an old companion

(2016) Sangeeta Sastry et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance

(2015) Sangeeta Sastry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Perceptions and behaviours of infectious diseases physicians when managing urinary tract infections due to MDR organisms

(2015) Sergio E. Trevino et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Urinary tract infections: epidemiology, mechanisms of infection and treatment options

(2015) Ana L. Flores-Mireles et al.   NATURE REVIEWS MICROBIOLOGY

The emerging threat of multidrug-resistant Gram-negative bacteria in urology

(2015) Hosam M. Zowawi et al.   Nature Reviews Urology

Fosfomycin Susceptibility in Carbapenem-Resistant Enterobacteriaceae from Germany

(2014) M. Kaase et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The Use of Fosfomycin to Treat Urinary Tract Infections in Kidney Transplant Recipients

(2013) Gail E. Reid et al.   TRANSPLANTATION

Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study

(2013) Lu-Dong Qiao et al.   BMJ Open

Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms

(2012) Elizabeth A. Neuner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Potential Role of Fosfomycin in the Treatment of Community-Acquired Lower Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli

(2011) Dustin T. Wilson et al.   AMERICAN JOURNAL OF THERAPEUTICS

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

(2011) Kalpana Gupta et al.   CLINICAL INFECTIOUS DISEASES

Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective

(2011) Johan W. Mouton et al.   DRUG RESISTANCE UPDATES

The revival of fosfomycin

(2011) Argyris S. Michalopoulos et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review

(2009) Matthew E Falagas et al.   LANCET INFECTIOUS DISEASES